Cocaine attenuates acid sphingomyelinase activity during establishment of addiction‐related behavior—A translational study in rats and monkeys

Abstract

Cocaine addiction is a severe psychiatric condition for which currently no effective pharmacotherapy is available. Brain mechanisms for the establishment of addiction‐related behaviors are still not fully understood, and specific biomarkers for cocaine use are not available. Sphingolipids are major membrane lipids, which shape neuronal membrane composition and dynamics in the brain. Here, we investigated how chronic cocaine exposure during establishment of addiction‐related behaviors affects the activity of the sphingolipid rheostat controlling enzymes in the brain of rats. As we detected specific effects on several enzymes in the brain, we tested whether the activity of selected enzymes in the blood may serve as potential biomarker for cocaine exposure in non‐human primates (Callithrix penicillata). We found that intravenous cocaine self‐administration led to a reduced mRNA expression of Cers1, Degs1 and Degs2, and Smpd1 in the prefrontal cortex of rats, as well as a reduction of Cers4 expression in the striatum. These effects reversed after 10 days of abstinence. Monkeys showed a robust cocaine‐induced place preference (CPP). This coincided with a reduction in blood acid sphingomyelinase (ASM) activity after CPP establishment. This effect normalized after 15 days of abstinence. Altogether, these findings suggest that the establishment of cocaine addiction‐related behaviors coincides with changes in the activity of sphingolipid controlling enzymes. In particular, blood ASM levels may serve as a translational biomarker for recent cocaine exposure.

Neutral sphingomyelinase mediates the co-morbidity trias of alcohol abuse, major depression and bone defects

“…However, compensatory changes in the activities of other enzymes of this pathway, particularly ASM or acid and neutral ceramidases, might also be involved in the observed behavioural endophenotype. These enzymes were recently shown to contribute to drug addiction [ 19 , 32 , 57 ], emotional phenotypes [ 8 , 58 ], and cognitive behaviours in rodents [ 42 , 59 ]. However, NSM is the only enzyme of ceramide synthesis and metabolism shown to mediate bone–brain signalling in the co-morbidity trias of alcohol addiction—depression/anxiety—osteoporosis.…”